Northern Survey on Therapeutic Oxygen Prescription

• Conditions: Oxygen Toxicity

• Registration Number: NCT03937622
• Lead Sponsor: Hannover Medical School

Brief Summary

This is a prospective multicenter observational trial. Included patients and attending physician complete a standardized questionnaire.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2019-05-02
• Study First Submitted QC: 2019-05-02
• Study First Posted: 2019-05-06
• Study Start: 2019-07-02
• Status Verified: 2019-08
• Last Update Submitted: 2019-08-06
• Last Update Posted: 2019-08-07
• Primary Completion: 2021-06-20
• Study Completion: 2021-09-20

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

• Patients with chronic lung disease, age > 18 years
• Established domiciliary LTOT > 4 weeks
• Scheduled for control of oxygen therapy with arterial/capillary

Read More

Exclusion Criteria

• No informed consent
• Pulmonary exacerbation within the last 2 weeks
• Signs of heart failure (edema, congestion)

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Validation of indication of Long-term Oxygen therapy (LTOT)	12 month	Aim of this study is to observe the real-world handling with longterm Oxygen treatment in northern Germany

Trial Locations

Locations (2)

Department of Respiratory Medicine, Medizinische Hochschule Hannover; 🇩🇪 Hannover, Germany

Dep. Respiratory Medicine, Hannover Medical School; 🇩🇪 Hannover, Germany